Observational studyIntensive care medicine2025

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Jason A Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.